Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) Revenue (2016 - 2025)

Historic Revenue for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $43.4 million.

  • Ultralife's Revenue rose 2150.78% to $43.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $186.5 million, marking a year-over-year increase of 1294.44%. This contributed to the annual value of $164.5 million for FY2024, which is 366.35% up from last year.
  • As of Q3 2025, Ultralife's Revenue stood at $43.4 million, which was up 2150.78% from $48.6 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Revenue registered a high of $50.7 million during Q1 2025, and its lowest value of $26.0 million during Q1 2021.
  • Moreover, its 4-year median value for Revenue was $42.7 million (2023), whereas its average is $39.9 million.
  • Data for Ultralife's Revenue shows a peak YoY increase of 3136.67% (in 2024) and a maximum YoY decrease of 960.8% (in 2024) over the last 5 years.
  • Ultralife's Revenue (Quarter) stood at $26.8 million in 2021, then surged by 66.41% to $44.5 million in 2023, then fell by 1.56% to $43.9 million in 2024, then fell by 1.1% to $43.4 million in 2025.
  • Its last three reported values are $43.4 million in Q3 2025, $48.6 million for Q2 2025, and $50.7 million during Q1 2025.